A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

A Non-Interventional Clinical Study to Assess the Risk and Performance Aspects of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05126407

Enrollment

Registered

2021-11-19

Start date

2021-12-17

Completion date

2022-01-20

Last updated

2023-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Cold, Hypersensitivity, Sinusitis

Brief summary

The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Aged 18 years or older who has personally used or administered the nasal drops/spray to a child * Has personally used or administered to a child, the Nasal Drops/Spray at least once within the past 6 months * Able to read, write, speak, and understand German * Has internet access to complete an on-line survey * Intends to complete the survey * Individual has signed the informed consent document (ICD)

Exclusion criteria

\- Is an employee/contractor or immediate family member of the principal investigator (PI), Schlesinger group, product perceptions limited (PPL) Insights or sponsor of this study

Design outcomes

Primary

Measure	Time frame	Description
Participant Feedback on the Performance Aspects of Olynth Nasal Saline Drops	Up to 1 month and 14 days	Participant feedback on the performance aspects of Olynth Nasal Saline Drops will be assessed via electronic survey.
Participant Feedback on the Performance Aspects of Olynth Nasal Saline Spray	Up to 1 month and 14 days	Participant feedback on the performance aspects of Olynth Nasal Saline Spray will be assessed via electronic survey.
Participant Feedback on the Performance Aspects of Olynth Ectomed Nasal Spray	Up to 1 month and 14 days	Participant feedback on the performance aspects of Olynth Ectomed Nasal Spray will be assessed via electronic survey.
Number of Participants with Adverse Events (AEs)	Up to 1 month and 14 days	An AE is any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in participants, users or other persons, whether or not related to the investigational device.

Countries

Germany

Outcome results